NCT06610604 Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules
| NCT ID | NCT06610604 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ming-an Yu |
| Condition | Thyroid Nodule |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2022-08-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this observational research is to evaluate and compare the health-related quality of life and emotional well-being of patients with thyroid nodules before and after treatment. This is a data collection study by allowing investigators to access information generated before and after treatment.
Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of benign thyroid nodules or papillary thyroid carcinoma ; * underwent microwave ablation or thyroidectomy; * ability to understand and cooperate with the survey Exclusion Criteria: * serious primary diseases in the liver, kidney, hematopoietic, or endocrine systems； * a history of mental illness, personality disorders, cognitive impairments, or organic brain disease
Contact & Investigator
ming'an yu, MD
STUDY CHAIR
China-JapanFriendship Hospital
Frequently Asked Questions
Who can join the NCT06610604 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Thyroid Nodule. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06610604 currently recruiting?
Yes, NCT06610604 is actively recruiting participants. Contact the research team at yma301@163.com for enrollment information.
Where is the NCT06610604 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06610604 clinical trial?
NCT06610604 is sponsored by Ming-an Yu. The principal investigator is ming'an yu, MD at China-JapanFriendship Hospital. The trial plans to enroll 500 participants.